It was the kind of news the health insurance sector had been waiting for. On Tuesday, the Centers for Medicare and Medicaid Services announced it would raise the amount it pays private insurers to administer Medicare Advantage plans by nearly 2.5% next year, an increase worth roughly $13 billion. In January, the agency had proposed a rate increase of less than 0.1%, or about $700 million.
The reversal landed like a relief valve for a sector that has spent more than a year absorbing rising costs, political backlash over healthcare prices and mounting scrutiny from Washington.
How Medicare stocks responded
UnitedHealth Group, the country’s largest health insurer, rose more than 10% on Tuesday, making it the best-performing stock in both the S&P 500 and the Dow Jones Industrial Average. Humana gained about 9%. CVS Health, which owns Aetna, climbed 6%, and Elevance Health advanced 3%.
Smaller companies in the Medicare space also saw sharp moves. Agilon health jumped 13.6%, while Evolent Health rose 12.4%. Astrana Health gained 7% and Fortrea climbed 3.6%.
The across-the-board jump reflected how much the sector had been waiting for a break. Even with Tuesday’s gains, UnitedHealth shares are down more than 40% over the past 12 months and have lost roughly half their value from their 2024 highs. Humana has shed about 20% since January. Elevance has dropped roughly 11% over the same period, and CVS Health is down about 2%.
Why the sector has struggled
Health insurance companies have been squeezed from multiple directions. Medical costs have climbed faster than expected, and the political environment has grown increasingly hostile. President Trump came into office pledging to lower drug prices and crack down on pharmacy benefit managers, the intermediaries that help set those prices, and his administration has launched investigations into insurers’ Medicare billing practices.
Congressional Democrats made the high cost of health insurance a central issue during last year’s government shutdown, the largest in American history. The combination of rising expenses, regulatory pressure and political exposure had weighed heavily on the sector for months before Tuesday’s announcement.
What the Medicare rate increase means
The higher payment rate is significant because it raises the revenue insurers collect per patient from federal funds without increasing their operating costs. Analysts said the change is projected to improve profit margins across major providers.
Medicare Advantage plans, which are privately administered alternatives to traditional Medicare, have grown substantially over the past decade. Tens of millions of Americans are enrolled, making the government’s payment rate one of the most consequential levers in the entire health insurance market.
Whether Tuesday’s gains hold will depend on whether the sector can translate the higher rates into sustained earnings improvement, particularly as medical cost trends remain elevated heading into 2026. Agilon health, for instance, had told investors just weeks earlier that its cost trends were expected to grow 7.5% this year, a forecast that had already rattled the stock before Tuesday’s bounce.
The Medicare update offers a clearer runway than the sector has had in some time. Whether insurers can capitalize on it is a different question.